Open Exploration Publishing Inc. has been a member of Open Access Scholarly Publishing Association (OASPA) since November 22, 2021.
OASPA is a membership organization that was established in 2008, which is the international community for open access publishing, works to encourage and enable open access as the predominant model of communication for scholarly outputs, and represents a diverse community of organizations engaged in open scholarship. It is committed to the mission of developing and disseminating solutions that advance open access and ensure a diverse, vibrant, and healthy open access community. Also, it represents the very best in open access publishing and enjoys a high reputation in the publishing industry. OASPA applies rigorous criteria and in-depth review to all members who must then continue to exemplify high standards to remain part of OASPA. The complete list of OASPA member organizations, including Open Exploration, can be found: Members - OASPA.
Open Exploration (Open Exploration Publishing), the Publisher and owner of Exploration of Neuroprotective Therapy (ENT), is a newborn open access publisher which was registered in New York in 2019 (business address is located in Xi’an, China). The mission of Open Exploration is to facilitate scientific and technological advance by disseminating high-quality content rapidly, widely and freely. As a member of OASPA, Open Exploration will take this chance to comply with the latest guidance of it, and work with OASPA as well as all members to advance research worldwide. And ENT will also uphold the mission of Open Exploration and adhere to publishing more high-quality articles with fast and professional services to promote the development and progress of neuroscience research.
COPE Membership of Exploration of Neuroprotective Therapy Approved
ENT’s Editorial Board Member is actively promoting the journal’s Scopus inclusion news
Exploration of Neuroprotective Therapy accepted for Scopus
ENT promoted in the International Congress on Neurodegenerative Diseases ICND2024